Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Astrazeneca Plc ADR (AZN)
Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Astrazeneca (AZN) Gains But Lags Market: What You Should Know

In the latest trading session, Astrazeneca (AZN) closed at $68.64, marking a +0.06% move from the previous day.

AZN : 69.20 (+0.82%)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment

Sanofi and Regeneron bolted higher on news about their jointly developed COPD medication Dupixent. Analysts say sales may hit $20 billion within a decade.

SNY : 53.97 (-0.88%)
REGN : 811.50 (-0.96%)
AZN : 69.20 (+0.82%)
GSK : 35.27 (+0.60%)
Ionis (IONS) Posts New Upbeat Data From Amyloidosis Drug Study

Ionis (IONS) reports positive long-term phase III study data, supporting the benefits of eplontersen as a treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).

AZN : 69.20 (+0.82%)
NVS : 91.58 (+1.54%)
BIIB : 275.13 (+0.41%)
IONS : 34.89 (-1.66%)
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks

Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints...

AZN : 69.20 (+0.82%)
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%

Regeneron's (REGN) share price rose after it reported data from a late-stage study showing that treatment with Dupixent led to a 30% decline in chronic obstructive pulmonary disease exacerbations.

REGN : 811.50 (-0.96%)
SNY : 53.97 (-0.88%)
AZN : 69.20 (+0.82%)
GSK : 35.27 (+0.60%)
4 Best Pharma Stocks to Buy for the Long Haul

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy...

ABMD : 381.02 (+0.06%)
AZN : 69.20 (+0.82%)
BMY : 68.20 (+0.03%)
CINC : 29.06 (-0.48%)
JNJ : 153.43 (+0.08%)
NVS : 91.58 (+1.54%)
Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should Know

Astrazeneca (AZN) closed the most recent trading day at $67.26, moving +1.04% from the previous trading session.

AZN : 69.20 (+0.82%)
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

NEOG : 17.45 (-5.62%)
AZN : 69.20 (+0.82%)
3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030

These historically profitable dividend-paying stocks are ideal for risk-averse investors wanting to take advantage of a bear market discount.

COMP : 3.07 (+0.33%)
V : 222.36 (-0.42%)
YORW : 44.53 (+0.11%)
AZN : 69.20 (+0.82%)
3 Best Stocks to Buy Now for Long-Term Investors

Recent turmoil in the financial sector, renewed recession worries, and the Fed’s continued rate hikes paint an unfavorable picture for the stock market and economy. Amid this, long-term investors could...

ABEV : 2.87 (+0.35%)
AZN : 69.20 (+0.82%)
CS : 0.8708 (-0.74%)
CSCO : 51.43 (+0.51%)
FRC : 13.69 (-4.00%)
GS : 321.14 (+0.13%)
PNC : 127.03 (-1.47%)
SBNY : 0.1888 (-21.33%)
SIVB : 106.04 (-60.41%)
TMUS : 144.57 (+0.53%)

Barchart Exclusives

S&P Futures Tick Higher Ahead of Key U.S. Inflation Data
June S&P 500 futures (ESM23) are trending up +0.16% this morning after three major U.S. benchmark indices closed higher on Thursday as technology-related shares continued to shine, while investors braced for crucial inflation data for more clues on Federal Reserve’s next rate moves. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar